Alistair Wheeler
Company: BioMarck Pharmaceuticals
Job title: Chief Medical Officer
Seminars:
Panel Discussion: Considering Early Endpoints in Clinical Trials to Benchmark ARDS Therapeutic Progress & Confidently Prove Proof of Concept 9:15 am
day: Day One
Leveraging Pilot Study Data, Options for Dosage & Statistics to Achieve Optimum ARDS Clinical Trial Design 8:00 am
Utilizing data of a pilot study to inform the design of adequate and well controlled studies Reviewing options for dose-ranging in ARDS studies Exploring the statistical implications of treatment benefit in the design of adequate and well-controlled studiesRead more
day: Day One